Skip to content
Slotmark845

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Deal Because of Information Apprehensions

Medical aid illustration
The offered US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive data.

The decision was revealed following a official document from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".

A government spokesman later explained that the US was seeking biological samples for research and profit but refused to guarantee the benefits from any future treatments.

"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for continued negotiations to find a deal suitable to both sides so the country's vital HIV treatment initiative can continue.

Broader Background

This rejection follows a similar case in neighbouring Kenya, where a court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.

After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

The agency had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and accountability.

According to reports, Sixteen African countries have to date agreed to similar agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy through US-supported programmes," the Ambassador added.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, without any corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"In essence, our nation would supply the raw materials for medical research with no certainty that the end products would be accessible to our citizens should a new disease outbreak arise."

National Interest and Global Health

Mangwana further noted that the American exit from the global health body and its push of one-on-one deals were disrupting frameworks previously established through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.

"This framework is designed to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be arranged in a manner that respects the independence and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but suggested that negotiations need to persist since much of the country's Aids initiatives depended on external financing.

"In cases where specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.

This impasse underscores the continuing challenges between accepting crucial international aid and protecting a country's data in an increasingly data-driven world.

Written by

Danielle Brown

A gaming enthusiast and writer with over a decade of experience in the online casino industry, specializing in slot machine analysis.

Slotmark845

Type to search articles.